Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT : rationale for further study on blood pressure targets of antihypertensive treatment after stroke
autor
vastutusandmed
Alberto Zanchetti, Lisheng Liu, Giuseppe Mancia, Gianfranco Parati, Guido Grassi, Marco Stramba-Badiale, Vincenzo Silani, Grzegorz Bilo, Giovanni Corrao, Antonella Zambon, Lorenza Scotti, Xinhua Zhang, Ting Rui Guan, Yuqing Zhang, Xuezhong Zhang, Eivind Berge, Josep Redon, Krzysztof Narkiewicz, Anna Dominiczak, Peter Nilsson, Margus Viigimaa, Stéphane Laurent, Enrico Agabiti-Rosei, Zhaosu Wu, Dingliang Zhu, José Luis Rodicio, Luis Miguel Ruilope, Nieves Martell-Claros, Fernando Pinto, Roland E. Schmieder, Michel Burnier, Maciej Banach, Renata Cifkova, Csaba Farsang, Alexandra Konradi, Irina Lazareva, Yuriy Sirenko, Maria Dorobantu, Arman Postadzhiyan, Rok Accetto, Bojan Jelakovic, Dragan Lovic, Athanasios J. Manolis, Philippos Stylianou, Dror Dicker, Gangzhi Wei, Chengbin Xu, Hengge Xie, Antonio Coca, John O'Brien, Gary Ford
allikas
kirjastus/väljaandja
ajakirja aastakäik number kuu
vol. 34, 3
ilmumisaasta
leheküljed
p. 393-396
ISSN
1473-5598
teaduspublikatsioon
teaduspublikatsioon
keel
inglise
märksõna
klassifikaator
kvartiil
TTÜ struktuuriüksus
Zanchetti, A., Liu, L., Mancia, G., Viigimaa, M. et al. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT : rationale for further study on blood pressure targets of antihypertensive treatment after stroke // Journal of hypertension (2016) vol. 34, 3, p. 393-396.